Cross-reactive antibody to swine influenza A(H3N2) subtype virus in children and adults before and after immunisation with 2010/11 trivalent inactivated influenza vaccine in Canada, August to November 2010
Identifieur interne :
001A57 ( PascalFrancis/Curation );
précédent :
001A56;
suivant :
001A58
Cross-reactive antibody to swine influenza A(H3N2) subtype virus in children and adults before and after immunisation with 2010/11 trivalent inactivated influenza vaccine in Canada, August to November 2010
Auteurs : D. M. Skowronski [
Canada] ;
G. De Serres [
Canada] ;
N. Z. Janjua [
Canada] ;
J. L. Gardy [
Canada] ;
V. Gilca [
Canada] ;
M. Dionne [
Canada] ;
M. E. Hamelin [
Canada] ;
C. Rheaume [
Canada] ;
G. Boivin [
Canada]
Source :
-
Euro surveillance [ 1025-496X ] ; 2012.
RBID : Pascal:13-0085949
Descripteurs français
- Pascal (Inist)
- Grippe,
Réaction croisée,
Anticorps,
Soustype,
Animal,
Virus grippal A,
Enfant,
Typage,
Adulte,
Prévention,
Vaccination,
Souche inactivée,
Canada,
Santé publique,
Surveillance sanitaire.
- Wicri :
English descriptors
- KwdEn :
- Adult,
Animal,
Antibody,
Canada,
Child,
Cross reaction,
Inactivated strain,
Influenza,
Influenza A virus,
Prevention,
Public health,
Sanitary surveillance,
Subtype,
Typing,
Vaccination.
pA |
A01 | 01 | 1 | | @0 1025-496X |
---|
A03 | | 1 | | @0 Euro surveill. |
---|
A06 | | | | @2 DEC @3 NS |
---|
A08 | 01 | 1 | ENG | @1 Cross-reactive antibody to swine influenza A(H3N2) subtype virus in children and adults before and after immunisation with 2010/11 trivalent inactivated influenza vaccine in Canada, August to November 2010 |
---|
A09 | 01 | 1 | ENG | @1 INFLUENZA - EXPERIENCES FROM THE 2009 PANDEMIC AND THE FOLLOWING SEASONS |
---|
A11 | 01 | 1 | | @1 SKOWRONSKI (D. M.) |
---|
A11 | 02 | 1 | | @1 DE SERRES (G.) |
---|
A11 | 03 | 1 | | @1 JANJUA (N. Z.) |
---|
A11 | 04 | 1 | | @1 GARDY (J. L.) |
---|
A11 | 05 | 1 | | @1 GILCA (V.) |
---|
A11 | 06 | 1 | | @1 DIONNE (M.) |
---|
A11 | 07 | 1 | | @1 HAMELIN (M. E.) |
---|
A11 | 08 | 1 | | @1 RHEAUME (C.) |
---|
A11 | 09 | 1 | | @1 BOIVIN (G.) |
---|
A14 | 01 | | | @1 British Columbia Centre for Disease Control @2 Vancouver @3 CAN @Z 1 aut. @Z 3 aut. @Z 4 aut. |
---|
A14 | 02 | | | @1 University of British Columbia @2 Vancouver @3 CAN @Z 1 aut. @Z 3 aut. @Z 4 aut. |
---|
A14 | 03 | | | @1 Institut National de Santé Publique du Quebec (National Institute of Health of Quebec) @2 Quebec @3 CAN @Z 2 aut. @Z 5 aut. @Z 6 aut. |
---|
A14 | 04 | | | @1 Laval University @2 Quebec @3 CAN @Z 2 aut. @Z 5 aut. @Z 6 aut. @Z 7 aut. @Z 9 aut. |
---|
A14 | 05 | | | @1 Centre Hospitalier Universitaire de Quebec (University Hospital Centre of Quebec) @2 Quebec @3 CAN @Z 2 aut. @Z 5 aut. @Z 6 aut. @Z 7 aut. @Z 8 aut. @Z 9 aut. |
---|
A20 | | | | @1 125-132 |
---|
A21 | | | | @1 2012 |
---|
A23 | 01 | | | @0 ENG |
---|
A43 | 01 | | | @1 INIST @2 26438 @5 354000506332710150 |
---|
A44 | | | | @0 0000 @1 © 2013 INIST-CNRS. All rights reserved. |
---|
A45 | | | | @0 25 ref. |
---|
A47 | 01 | 1 | | @0 13-0085949 |
---|
A60 | | | | @1 P @3 CC |
---|
A61 | | | | @0 A |
---|
A64 | 01 | 1 | | @0 Euro surveillance |
---|
A66 | 01 | | | @0 FRA |
---|
C02 | 01 | X | | @0 002B05C02C |
---|
C03 | 01 | X | FRE | @0 Grippe @5 01 |
---|
C03 | 01 | X | ENG | @0 Influenza @5 01 |
---|
C03 | 01 | X | SPA | @0 Gripe @5 01 |
---|
C03 | 02 | X | FRE | @0 Réaction croisée @5 07 |
---|
C03 | 02 | X | ENG | @0 Cross reaction @5 07 |
---|
C03 | 02 | X | SPA | @0 Reacción cruzada @5 07 |
---|
C03 | 03 | X | FRE | @0 Anticorps @5 08 |
---|
C03 | 03 | X | ENG | @0 Antibody @5 08 |
---|
C03 | 03 | X | SPA | @0 Anticuerpo @5 08 |
---|
C03 | 04 | X | FRE | @0 Soustype @5 09 |
---|
C03 | 04 | X | ENG | @0 Subtype @5 09 |
---|
C03 | 04 | X | SPA | @0 Subtipo @5 09 |
---|
C03 | 05 | X | FRE | @0 Animal @5 10 |
---|
C03 | 05 | X | ENG | @0 Animal @5 10 |
---|
C03 | 05 | X | SPA | @0 Animal @5 10 |
---|
C03 | 06 | X | FRE | @0 Virus grippal A @2 NW @5 11 |
---|
C03 | 06 | X | ENG | @0 Influenza A virus @2 NW @5 11 |
---|
C03 | 06 | X | SPA | @0 Influenza A virus @2 NW @5 11 |
---|
C03 | 07 | X | FRE | @0 Enfant @5 12 |
---|
C03 | 07 | X | ENG | @0 Child @5 12 |
---|
C03 | 07 | X | SPA | @0 Niño @5 12 |
---|
C03 | 08 | X | FRE | @0 Typage @5 13 |
---|
C03 | 08 | X | ENG | @0 Typing @5 13 |
---|
C03 | 08 | X | SPA | @0 Tipificación @5 13 |
---|
C03 | 09 | X | FRE | @0 Adulte @5 14 |
---|
C03 | 09 | X | ENG | @0 Adult @5 14 |
---|
C03 | 09 | X | SPA | @0 Adulto @5 14 |
---|
C03 | 10 | X | FRE | @0 Prévention @5 15 |
---|
C03 | 10 | X | ENG | @0 Prevention @5 15 |
---|
C03 | 10 | X | SPA | @0 Prevención @5 15 |
---|
C03 | 11 | X | FRE | @0 Vaccination @5 16 |
---|
C03 | 11 | X | ENG | @0 Vaccination @5 16 |
---|
C03 | 11 | X | SPA | @0 Vacunación @5 16 |
---|
C03 | 12 | X | FRE | @0 Souche inactivée @5 17 |
---|
C03 | 12 | X | ENG | @0 Inactivated strain @5 17 |
---|
C03 | 12 | X | SPA | @0 Cepa inactivada @5 17 |
---|
C03 | 13 | X | FRE | @0 Canada @2 NG @5 18 |
---|
C03 | 13 | X | ENG | @0 Canada @2 NG @5 18 |
---|
C03 | 13 | X | SPA | @0 Canadá @2 NG @5 18 |
---|
C03 | 14 | X | FRE | @0 Santé publique @5 20 |
---|
C03 | 14 | X | ENG | @0 Public health @5 20 |
---|
C03 | 14 | X | SPA | @0 Salud pública @5 20 |
---|
C03 | 15 | X | FRE | @0 Surveillance sanitaire @5 30 |
---|
C03 | 15 | X | ENG | @0 Sanitary surveillance @5 30 |
---|
C03 | 15 | X | SPA | @0 Vigilancia sanitaria @5 30 |
---|
C07 | 01 | X | FRE | @0 Virose |
---|
C07 | 01 | X | ENG | @0 Viral disease |
---|
C07 | 01 | X | SPA | @0 Virosis |
---|
C07 | 02 | X | FRE | @0 Infection |
---|
C07 | 02 | X | ENG | @0 Infection |
---|
C07 | 02 | X | SPA | @0 Infección |
---|
C07 | 03 | X | FRE | @0 Influenzavirus A @2 NW |
---|
C07 | 03 | X | ENG | @0 Influenzavirus A @2 NW |
---|
C07 | 03 | X | SPA | @0 Influenzavirus A @2 NW |
---|
C07 | 04 | X | FRE | @0 Orthomyxoviridae @2 NW |
---|
C07 | 04 | X | ENG | @0 Orthomyxoviridae @2 NW |
---|
C07 | 04 | X | SPA | @0 Orthomyxoviridae @2 NW |
---|
C07 | 05 | X | FRE | @0 Virus @2 NW |
---|
C07 | 05 | X | ENG | @0 Virus @2 NW |
---|
C07 | 05 | X | SPA | @0 Virus @2 NW |
---|
C07 | 06 | X | FRE | @0 Homme |
---|
C07 | 06 | X | ENG | @0 Human |
---|
C07 | 06 | X | SPA | @0 Hombre |
---|
C07 | 07 | X | FRE | @0 Amérique du Nord @2 NG |
---|
C07 | 07 | X | ENG | @0 North America @2 NG |
---|
C07 | 07 | X | SPA | @0 America del norte @2 NG |
---|
C07 | 08 | X | FRE | @0 Amérique @2 NG |
---|
C07 | 08 | X | ENG | @0 America @2 NG |
---|
C07 | 08 | X | SPA | @0 America @2 NG |
---|
C07 | 09 | X | FRE | @0 Exploration microbiologique @5 37 |
---|
C07 | 09 | X | ENG | @0 Microbiological investigation @5 37 |
---|
C07 | 09 | X | SPA | @0 Análisis microbiológico @5 37 |
---|
N21 | | | | @1 056 |
---|
N44 | 01 | | | @1 OTO |
---|
N82 | | | | @1 OTO |
---|
|
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000369
Links to Exploration step
Pascal:13-0085949
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Cross-reactive antibody to swine influenza A(H3N2) subtype virus in children and adults before and after immunisation with 2010/11 trivalent inactivated influenza vaccine in Canada, August to November 2010</title>
<author><name sortKey="Skowronski, D M" sort="Skowronski, D M" uniqKey="Skowronski D" first="D. M." last="Skowronski">D. M. Skowronski</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>British Columbia Centre for Disease Control</s1>
<s2>Vancouver</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>University of British Columbia</s1>
<s2>Vancouver</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="De Serres, G" sort="De Serres, G" uniqKey="De Serres G" first="G." last="De Serres">G. De Serres</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Institut National de Santé Publique du Quebec (National Institute of Health of Quebec)</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Laval University</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Centre Hospitalier Universitaire de Quebec (University Hospital Centre of Quebec)</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Janjua, N Z" sort="Janjua, N Z" uniqKey="Janjua N" first="N. Z." last="Janjua">N. Z. Janjua</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>British Columbia Centre for Disease Control</s1>
<s2>Vancouver</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>University of British Columbia</s1>
<s2>Vancouver</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Gardy, J L" sort="Gardy, J L" uniqKey="Gardy J" first="J. L." last="Gardy">J. L. Gardy</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>British Columbia Centre for Disease Control</s1>
<s2>Vancouver</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>University of British Columbia</s1>
<s2>Vancouver</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Gilca, V" sort="Gilca, V" uniqKey="Gilca V" first="V." last="Gilca">V. Gilca</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Institut National de Santé Publique du Quebec (National Institute of Health of Quebec)</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Laval University</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Centre Hospitalier Universitaire de Quebec (University Hospital Centre of Quebec)</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Dionne, M" sort="Dionne, M" uniqKey="Dionne M" first="M." last="Dionne">M. Dionne</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Institut National de Santé Publique du Quebec (National Institute of Health of Quebec)</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Laval University</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Centre Hospitalier Universitaire de Quebec (University Hospital Centre of Quebec)</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Hamelin, M E" sort="Hamelin, M E" uniqKey="Hamelin M" first="M. E." last="Hamelin">M. E. Hamelin</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Laval University</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Centre Hospitalier Universitaire de Quebec (University Hospital Centre of Quebec)</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Rheaume, C" sort="Rheaume, C" uniqKey="Rheaume C" first="C." last="Rheaume">C. Rheaume</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Centre Hospitalier Universitaire de Quebec (University Hospital Centre of Quebec)</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Boivin, G" sort="Boivin, G" uniqKey="Boivin G" first="G." last="Boivin">G. Boivin</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Laval University</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Centre Hospitalier Universitaire de Quebec (University Hospital Centre of Quebec)</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">13-0085949</idno>
<date when="2012">2012</date>
<idno type="stanalyst">PASCAL 13-0085949 INIST</idno>
<idno type="RBID">Pascal:13-0085949</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000369</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001A57</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Cross-reactive antibody to swine influenza A(H3N2) subtype virus in children and adults before and after immunisation with 2010/11 trivalent inactivated influenza vaccine in Canada, August to November 2010</title>
<author><name sortKey="Skowronski, D M" sort="Skowronski, D M" uniqKey="Skowronski D" first="D. M." last="Skowronski">D. M. Skowronski</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>British Columbia Centre for Disease Control</s1>
<s2>Vancouver</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>University of British Columbia</s1>
<s2>Vancouver</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="De Serres, G" sort="De Serres, G" uniqKey="De Serres G" first="G." last="De Serres">G. De Serres</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Institut National de Santé Publique du Quebec (National Institute of Health of Quebec)</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Laval University</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Centre Hospitalier Universitaire de Quebec (University Hospital Centre of Quebec)</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Janjua, N Z" sort="Janjua, N Z" uniqKey="Janjua N" first="N. Z." last="Janjua">N. Z. Janjua</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>British Columbia Centre for Disease Control</s1>
<s2>Vancouver</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>University of British Columbia</s1>
<s2>Vancouver</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Gardy, J L" sort="Gardy, J L" uniqKey="Gardy J" first="J. L." last="Gardy">J. L. Gardy</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>British Columbia Centre for Disease Control</s1>
<s2>Vancouver</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>University of British Columbia</s1>
<s2>Vancouver</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Gilca, V" sort="Gilca, V" uniqKey="Gilca V" first="V." last="Gilca">V. Gilca</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Institut National de Santé Publique du Quebec (National Institute of Health of Quebec)</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Laval University</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Centre Hospitalier Universitaire de Quebec (University Hospital Centre of Quebec)</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Dionne, M" sort="Dionne, M" uniqKey="Dionne M" first="M." last="Dionne">M. Dionne</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Institut National de Santé Publique du Quebec (National Institute of Health of Quebec)</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Laval University</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Centre Hospitalier Universitaire de Quebec (University Hospital Centre of Quebec)</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Hamelin, M E" sort="Hamelin, M E" uniqKey="Hamelin M" first="M. E." last="Hamelin">M. E. Hamelin</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Laval University</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Centre Hospitalier Universitaire de Quebec (University Hospital Centre of Quebec)</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Rheaume, C" sort="Rheaume, C" uniqKey="Rheaume C" first="C." last="Rheaume">C. Rheaume</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Centre Hospitalier Universitaire de Quebec (University Hospital Centre of Quebec)</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Boivin, G" sort="Boivin, G" uniqKey="Boivin G" first="G." last="Boivin">G. Boivin</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Laval University</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Centre Hospitalier Universitaire de Quebec (University Hospital Centre of Quebec)</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Euro surveillance</title>
<title level="j" type="abbreviated">Euro surveill.</title>
<idno type="ISSN">1025-496X</idno>
<imprint><date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Euro surveillance</title>
<title level="j" type="abbreviated">Euro surveill.</title>
<idno type="ISSN">1025-496X</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Animal</term>
<term>Antibody</term>
<term>Canada</term>
<term>Child</term>
<term>Cross reaction</term>
<term>Inactivated strain</term>
<term>Influenza</term>
<term>Influenza A virus</term>
<term>Prevention</term>
<term>Public health</term>
<term>Sanitary surveillance</term>
<term>Subtype</term>
<term>Typing</term>
<term>Vaccination</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Grippe</term>
<term>Réaction croisée</term>
<term>Anticorps</term>
<term>Soustype</term>
<term>Animal</term>
<term>Virus grippal A</term>
<term>Enfant</term>
<term>Typage</term>
<term>Adulte</term>
<term>Prévention</term>
<term>Vaccination</term>
<term>Souche inactivée</term>
<term>Canada</term>
<term>Santé publique</term>
<term>Surveillance sanitaire</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Canada</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Enfant</term>
<term>Adulte</term>
<term>Vaccination</term>
<term>Santé publique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>1025-496X</s0>
</fA01>
<fA03 i2="1"><s0>Euro surveill.</s0>
</fA03>
<fA06><s2>DEC</s2>
<s3>NS</s3>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Cross-reactive antibody to swine influenza A(H3N2) subtype virus in children and adults before and after immunisation with 2010/11 trivalent inactivated influenza vaccine in Canada, August to November 2010</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG"><s1>INFLUENZA - EXPERIENCES FROM THE 2009 PANDEMIC AND THE FOLLOWING SEASONS</s1>
</fA09>
<fA11 i1="01" i2="1"><s1>SKOWRONSKI (D. M.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>DE SERRES (G.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>JANJUA (N. Z.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>GARDY (J. L.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>GILCA (V.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>DIONNE (M.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>HAMELIN (M. E.)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>RHEAUME (C.)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>BOIVIN (G.)</s1>
</fA11>
<fA14 i1="01"><s1>British Columbia Centre for Disease Control</s1>
<s2>Vancouver</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>University of British Columbia</s1>
<s2>Vancouver</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Institut National de Santé Publique du Quebec (National Institute of Health of Quebec)</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Laval University</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Centre Hospitalier Universitaire de Quebec (University Hospital Centre of Quebec)</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</fA14>
<fA20><s1>125-132</s1>
</fA20>
<fA21><s1>2012</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>26438</s2>
<s5>354000506332710150</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2013 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>25 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>13-0085949</s0>
</fA47>
<fA60><s1>P</s1>
<s3>CC</s3>
</fA60>
<fA64 i1="01" i2="1"><s0>Euro surveillance</s0>
</fA64>
<fA66 i1="01"><s0>FRA</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B05C02C</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Grippe</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Influenza</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Gripe</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Réaction croisée</s0>
<s5>07</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Cross reaction</s0>
<s5>07</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Reacción cruzada</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Anticorps</s0>
<s5>08</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Antibody</s0>
<s5>08</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Anticuerpo</s0>
<s5>08</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Soustype</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Subtype</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Subtipo</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Animal</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Animal</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Animal</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Virus grippal A</s0>
<s2>NW</s2>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Influenza A virus</s0>
<s2>NW</s2>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Influenza A virus</s0>
<s2>NW</s2>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Enfant</s0>
<s5>12</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Child</s0>
<s5>12</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Niño</s0>
<s5>12</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Typage</s0>
<s5>13</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Typing</s0>
<s5>13</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Tipificación</s0>
<s5>13</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Adulte</s0>
<s5>14</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Adult</s0>
<s5>14</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Adulto</s0>
<s5>14</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Prévention</s0>
<s5>15</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Prevention</s0>
<s5>15</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Prevención</s0>
<s5>15</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Vaccination</s0>
<s5>16</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Vaccination</s0>
<s5>16</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Vacunación</s0>
<s5>16</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Souche inactivée</s0>
<s5>17</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Inactivated strain</s0>
<s5>17</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Cepa inactivada</s0>
<s5>17</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Canada</s0>
<s2>NG</s2>
<s5>18</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG"><s0>Canada</s0>
<s2>NG</s2>
<s5>18</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA"><s0>Canadá</s0>
<s2>NG</s2>
<s5>18</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE"><s0>Santé publique</s0>
<s5>20</s5>
</fC03>
<fC03 i1="14" i2="X" l="ENG"><s0>Public health</s0>
<s5>20</s5>
</fC03>
<fC03 i1="14" i2="X" l="SPA"><s0>Salud pública</s0>
<s5>20</s5>
</fC03>
<fC03 i1="15" i2="X" l="FRE"><s0>Surveillance sanitaire</s0>
<s5>30</s5>
</fC03>
<fC03 i1="15" i2="X" l="ENG"><s0>Sanitary surveillance</s0>
<s5>30</s5>
</fC03>
<fC03 i1="15" i2="X" l="SPA"><s0>Vigilancia sanitaria</s0>
<s5>30</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Virose</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Viral disease</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Virosis</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Infection</s0>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Infection</s0>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Infección</s0>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Influenzavirus A</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Influenzavirus A</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Influenzavirus A</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Orthomyxoviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Orthomyxoviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Orthomyxoviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Homme</s0>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Human</s0>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Hombre</s0>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Amérique du Nord</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>North America</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>America del norte</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Amérique</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>America</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>America</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="09" i2="X" l="FRE"><s0>Exploration microbiologique</s0>
<s5>37</s5>
</fC07>
<fC07 i1="09" i2="X" l="ENG"><s0>Microbiological investigation</s0>
<s5>37</s5>
</fC07>
<fC07 i1="09" i2="X" l="SPA"><s0>Análisis microbiológico</s0>
<s5>37</s5>
</fC07>
<fN21><s1>056</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A57 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 001A57 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= PascalFrancis
|étape= Curation
|type= RBID
|clé= Pascal:13-0085949
|texte= Cross-reactive antibody to swine influenza A(H3N2) subtype virus in children and adults before and after immunisation with 2010/11 trivalent inactivated influenza vaccine in Canada, August to November 2010
}}
| This area was generated with Dilib version V0.6.34. Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021 | |